Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD
Conditions: Liver Cirrhosis; Liver Fibrosis; Portal Hypertension Interventions: Diagnostic Test: Diagnostic Test: Transient elastography (TE) and 2D-shear wave elastography (2D-SWE) Sponsors: Fifth Affiliated Hospital, Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLD
Conditions: Liver Fibrosis; Liver Cirrhosis Interventions: Diagnostic Test: Diagnostic Test: Transient elastography (TE) and 2D-shear wave elastography (2D-SWE) Sponsors: Fifth Affiliated Hospital, Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis
Conditions: Compensated Cirrhosis; Decompensated Cirrhosis Interventions: Drug: Metformin; Drug: Sitagliptin; Drug: Dapagliflozin Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of GOV in Patients With cACLD
Conditions: Liver Cirrhosis; Liver Fibrosis; Portal Hypertension Interventions: Diagnostic Test: Transient elastography (TE) and 2D-shear wave elastography (2D-SWE) Sponsors: Fifth Affiliated Hospital, Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)
Conditions: Liver Cirrhosis Interventions: Drug: Foscenvivint Sponsors: Kiminori Kimura, MD; Japan Agency for Medical Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
Conditions: Cirrhosis, Liver; End Stage Liver DIsease; Symptoms and Signs; Physical Inactivity; Muscle Loss Interventions: Behavioral: LiverWatch Intervention Sponsors: University of Pennsylvania; Pennsylvania Department of Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Effect of IMO on Intestinal Microbiota Translocation in Cirrhosis
Conditions: Decompensated Cirrhosis Interventions: Dietary Supplement: Isomaltooligosaccharides (IMO) Sponsors: Nanfang Hospital, Southern Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia
Conditions: Hyperammonemia Interventions: Drug: TNP-2092 placebo capsules; Drug: TNP-2092 capsules Sponsors: TenNor Therapeutics (Suzhou) Limited Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
Conditions: Metabolic Dysfunction-associated Fatty Liver Disease; Cirrhosis Interventions: Drug: Pioglitazone metformin tablets; Drug: Other drugs; Other: Drug-free Sponsors: The Affiliated Hospital of Hangzhou Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Is There an Association Between Quadriceps Strength and Different Markers of Fragility in Patients With Cirrhosis?
Conditions: Cirrhosis Interventions: Other: Frailty assessment Sponsors: University Hospital, Clermont-Ferrand Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Intermittent ADVOS vs. Hemodialysis in Non-intensive Care Patients With Liver Dysfunction
Conditions: Liver Cirrhosis; Kidney Failure, Acute; Kidney Replacement; Multi Organ Failure Interventions: Device: Hemodialysis; Device: ADVOS Sponsors: University Medical Center Mainz; ADVITOS GmbH M ünchen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Oral Branched-chain Amino Acid Supplementation for Cirrhotic Patients With Sarcopenia
Conditions: Sarcopenia; Cirrhosis of the Liver Interventions: Drug: Branched-chain amino acid; Drug: Placebo Sponsors: Mahidol University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
Preemptive TIPS for Gastric Variceal Bleeding in Patients With Cirrhosis
Conditions: Portal Hypertension; Gastric Varices Bleeding; Portosystemic Shunt Interventions: Procedure: preemptive TIPS; Procedure: standard second prophylaxis Sponsors: West China Hospital; Beijing YouAn Hospital; Renmin Hospital of Wuhan University; Second Affiliated Hospital of Nanchang University; Guangzhou First People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
Role of Blood Lactate Level in Prediction of Outcome of Cirrhotic Patients at The Intensive Care Unit
Conditions: Liver Cirrhosis Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
Oral Branched-chain Amino Acid Supplementation for Decompensated Cirrhotic Patients
Conditions: Decompensated Cirrhosis and Ascites Interventions: Drug: Branched-chain amino acid Sponsors: Mahidol University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
